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Among the antikiiaics thut. hecxwe of their pocclini- 
Cal activities against \xwiaus turnours. are nowadays 
sehxted for phase I triah thmz is il new and nsvcl 
fermentation product: elsamicin A [-O-5& the binding of 
which to DNA has recently Beck chamctcriscd {&S]. 
This antibiotic appears to bind prcfcccntially to sc- 
quences comaining a CpG step. possibly as a tripkt 
YNCG3’ [6]. Morcwcr. clsztmicin products c?rlcmiw 
DNA brwkagc in &acZ cells i4] that can be 3!50 ob- 
scrvcd in vitro in the prcscncx of a reducing agent and 
Fe(ll’L [S]. in hc.. the chwmophorc moicry of ckmiciil 
(chanarinl acts ils a tnk catalpt promoting rhc produc- 
tion of hydra@ radicals that act as the ultimate r active 
species that cleaves DNA p.8). Vkeas the mecha- 
nisms of DNA breakage induced by elsamicin is well 
established by experimental [7.8] and theorelical [8] 
Gvidenrr, the exact composition of its sequence-sekctivc 
binding site nzmains partially unknawn, As mentioned 
above. it is perfectly established that the thicker binding 
site for els;(;micin A contains the CpG step [6]. but as for 
the antibiotic daunamycin (which contains a diffcrcnt 
chromophorc bound lo a sugar moiety [9], wc have 
tentatively suggcstcd that the scquencc specificity of el- 
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l:lg, I, Str~c~urul l’ormnlu dclrumluin (Id\ puncl) und pllrl ol’ the ubMxinLa% ul 421 mn w$rr~lW the conrrnWuriun or rhc unlibiolk ndrlcd to 
l\ncur{ad pBR3?? DNA (right pnct). The btndhlg dohiomctry wus dcrrluk.. llunr thin plot ULL dcs~ribd in Ihe arnin tcfl. 
3. RESULTS 
The binding stoichiornctry (r) wus dctcrmincd lhm 
the break in the straight lines rcsultiny from the plot 
displt\yed in Fii. 1, For the lintxrised pBR322 WC de- 
tcctcd one binding site, which saturates at about OIW 
clst\micin A molcculc per four base pairs (r = 0.251. lmd 
nnothcr wcukcr binding site that snturutcs nt n higher 
mtio of clsamicin to PM (P = 9.43). Tl~csc values were 
used to design a study on the inhibition of the cleavage 
of IiIleariscd pBR3__ 31by Rvo ditYiirent restcic~ion CII- 
zymcs (see sccrion, 2) in thr presenw/abscnw of elw- 
micin. We analyzed the differential reactivity at the 
restriction sites using input ratios of antibiotic to DNA 
around or below the stoichiomctric value, thus nnalyz- 
ily difkcnccs in cicavagc that could bc compiued 
stmightforwnrd. in o&r to dcfinc dif$ercnces in the 
antibiotic binding sites. The enzymes used in our esperi- 
mcnts, whose turgct sites RI‘C displayed in Fig. 2, have 
2 unique cutting site in pBR322. The recognition sites 
for hilI, ChI and Nrttl contain the CpG step that has 
been previously described by DNase Footprinting as a 
component of the sequence-selective sit for clsanlicin 
161. Digestion of BumHl linear&d pBR322 DNA by 
these enzymes results in the initial appearance of three 
bands after clectrophorcsis on an agarose gel. They iire 
the complete linearised pBR322 and two fragments, one 
~mallcr than the other, which are the products of the 
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enzyme cle~ag~ Fig 3 shows m cxam~lc sf such 
rcsulta (note thut the smullrr frqment hers migrated 160 
fur to bc seen). The four punch displnycd in 
the time coune of digestion of linc&rsnl 
Nrol in the ubscncc of elsumicin und in the presence of 
three dil%rent antibiotic/DNA input mtios. All the 
digestions wxc performed with cuch tmtrietion enzyme 
under conditions in which the rcuctions 
or&x kimtics, Fig, 4 presents u plot of the 
the relutivc umaunt of uecul pBW!2 vmu% 
time in the ptwmWttbYencx o~diffiscnt input ratios (r) 
ol’drug to DNA. As deswibtx! in szction 2. the slopes 
of thcsc plots \vere usei to caleulute the first-order pte 
constr\nts. I-lowcvcr, wc obtain& poor ~~pr0ducibilily 
in the culculntions of the first-o&r mtc constant for 
CW possibly Itfltxting SOIW unknown pcculioritis in 
A: 
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its kineric behataur, The ofebamdn inhibits 
Ynnl B) il cra~anc-rs the mtc of 
by mdll that do not IPzcqajniw 
sq- ccmtainiqj t Slcp lldd far !a3 
q-whi\x binding ofelsamicin i&r]. The meaning 
afthesPenhil ncements in rcstrktion enzyne cutting will 
he cmx&ked in the following discussion. 
Fig. 5 shaws, a comparison al the relative rate of 
Jigcstion of linearis pBRX2 DNA as a Cunction of 
the antibiotic added, Thaw plots show that Srart 
(rcco~lition ss!uence: TCGKTGA) cleavage is %I% in- 
hibited at an input ratio of about O.iS. whi?e .445 
(GACG!TC) i5 not khibitcd by more than If+%- tit rhc 
same nrio. htorwver. evekl though data t’or CM (AT; 
cGAI17 should be used with caution. for the 1ISsons 
given abow, the an+is of its agarose gels leads us to 
consider that the degree of inhibition is wen smatter 
than at the R@ll sites. These results are consistent with 
the sequent-selective binding ofekunicin within. or in 
the vicinity of. the Srul twognition site. 
4. DISCUSSION 
In this study, we have used restriction enzymes to 
disciose which is the preferential nucleotide (N) Iocztcd 
at the 5’ site of the elsamicin binding site: YNCCi3’ 
deduced from footprinting studies 16) The rationale of 
our approach is that a triplet appears to he a rnnrs’ 
‘realistic’ binding site for antibiotics consisting of a 
chromophorc plus a sugar moiety [2,9.13] than the CpG 
rlsamkin A campared to the Aatl, C&l, &&I and 
HkdtlI rxiaction OM in Fig. S iscomistmt with the 
preferential binding of elsamicin to the tripkt SQCG3’. 
~0 elsamicin appears to foibw an order of binding pre- 
fetUKe: TCG e ‘cc3 -c WCS. Hw a pufinc seems 
to PC fzwaurcd at the 9’ site. in contrast to what happy 
with daunomycin. in which a sequent containing an 
AT pair is fa\iou,~+ F,!J). lIw disaccharkk moiety of 
elsamkin ~wuld favnur diffewnt kk+ \f o A*,&% with 
thr n~icotidr5 at the 5’ site. nsr io mmtio;~ SAWIT d& 
dissimilarities that would arise from the diikrent 
agl~zone moiety NwertheIess. a nwre rigwow analysis 
of the possible strunural basis of the etsamicin sequence 
!5pxificity will require us to wait until lzrystnlEagraphic 
and NMR data are available. It is noteworthy that the 
rrlatcd antibiotk &.trtreti~ also e 0% 
triplet sequem [6.15]. 
The presence of the sequence TCCXGA at the NruI 
restriction (see Fig. 2) mises a question as to whether 
WC could bc obsc%ng a mkWe of bmdiigs to TCG 
and GCG sites. although because T’CG sites (digested 
by ck1) 35 xx:i~ protected we consider that the 
stronger protection arises mainly from &mkin bind- 
ing to SGCG3. The binding to alternating C+G se- 
+encszs is ywciaily interesting since one could conjec- 
ture that, because of that preference. elsamicin might 
&have as an antitumour drug by interfering With DNA 
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Hirtdlll und &oRI mction site do not cwntuin 
binding sites !‘oor clwmicin [a], see Fig. 2, md, thcwbt. 
no protcctiorr nf its cleaving uctivitp is dctcmd, hut 
r P 
Fig. 5. Cornpnrisott oFthc rcltt~iw rm ofdigoslion oflincttriscxi pBR312 DNA by CM. Aarll, ~VIWI (lst\ pancl) and Hirdlll and EwRI (tigk PawI) 
u tt I’utwtiOn 01’ ditktwt input ratios of cisau~icin to DNA. The datit show that inhibition of the clcuvag~ wttction occurs ttt Iowcr antibiotic 
COttwltrittion Tar Akr~ rclativr than for the other rcstrictioq euzymcs. Hirrdlll ttnd &(+crRI cleaving wrstions ark cnhancud by the pmsctxw of 
clsamicin A. 
28 
Volume 300, number I FEt3S UZI-TERS March 1992 
‘9 
